← Back to Search

Herbal Supplement

1 for Type 2 Diabetes

Phase 2
Waitlist Available
Led By Vladimir Vuksan, PhD
Research Sponsored by Unity Health Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks -4, 0, 6, 12
Awards & highlights

Study Summary

The study is a 2 phase double blind randomized placebo control trial. The objective is to asses the metabolic and therapeutic effects of American Ginseng (Panax quinquefolius L.) extract and Korean Red Ginseng (steamed Panax C.A. Meyer) extract in the management of type 2 diabetes in a 12 week period. One Hundred and twenty subjects with type 2 diabetes (hyperglycemia key inclusion criteria: HbAlc≥6.5% - ≤ 8.1% ) will participate in the study (36 men and 36 post-menopausal women).

Eligible Conditions
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks -4, 0, 6, 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks -4, 0, 6, 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
HbA1c levels and insulin sensitivity index using 3 different indices: ISI, HOMA, QUICKI
Secondary outcome measures
Cholesterol, triglycerides, fasting & post-prandial blood glucose and insulin, C-reactive protein, lipid peroxidation, blood pressure, endothelial function, body fat composition

Trial Design

3Treatment groups
Experimental Treatment
Placebo Group
Group I: 2Experimental Treatment1 Intervention
American Ginseng Capsules
Group II: 1Experimental Treatment1 Intervention
American Ginseng and American Red Ginseng Capsules
Group III: 3Placebo Group1 Intervention
Placebo Capsules

Find a Location

Who is running the clinical trial?

Unity Health TorontoLead Sponsor
536 Previous Clinical Trials
447,409 Total Patients Enrolled
Canadian Diabetes AssociationOTHER
42 Previous Clinical Trials
11,202 Total Patients Enrolled
Vladimir Vuksan, PhDPrincipal InvestigatorClinical Nutritian and Risk Factor Modification Centre
20 Previous Clinical Trials
5,956 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes
2008. "Metabolic and Therapeutic Effects of American and Korean Red Ginseng in the Treatment of Type 2 Diabetes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00728403.
All > Uti > Type 2 Diabetes
~7 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top